Status:

COMPLETED

Retrospective Study of ImmunoFormulation for COVID-19

Lead Sponsor:

Fagron Iberica S.A.U.

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Brief Summary

Multicentre, retrospective, observational study to describe the course of SARS-CoV-2 disease in patients treated or not with IMUNO TF ® and a combination of nutraceuticals and who have tested positive...

Detailed Description

SAMPLE SIZE JUSTIFICATION The primary objective of the study was to describe the course of SARS-CoV-2 disease in patients treated or not with IMUNO TF® and a combination of nutraceuticals and who have...

Eligibility Criteria

Inclusion

  • Patients aged 18 years or older.
  • Patients who give written informed consent to participate in the study.
  • Patients who have consulted their physician for symptoms associated with SARS-CoV-2 infection between March 2020 and May 2020. Patients were included in one cohort or the other based on the treatment received for improvement of COVID-19 symptoms:
  • IMUNO TF® cohort: patients treated\* with IMUNO TF® with a combination of nutraceuticals
  • Control cohort: patients not treated\* with IMUNO TF® with a combination of nutraceuticals \*Without restrictions on the adjuvant treatment received.
  • Patients who have tested positive in a diagnostic test for SARS-CoV-2.
  • Patients with onset of COVID-19 symptoms ≥ 5 days prior to diagnosis of SARS-CoV-2.
  • Patients with data in the medical record from the first visit due to disease symptoms until recovery, or at least 1 month of follow-up of symptoms, whichever occurs first.

Exclusion

  • Any medical or psychological condition that, in the physician's opinion, could compromise the patient's ability to give informed consent.
  • Patients requiring hospital admission due to the disease.

Key Trial Info

Start Date :

July 2 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 29 2020

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04666753

Start Date

July 2 2020

End Date

September 29 2020

Last Update

December 14 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Clinic Bascoy

Barcelona, Spain, 08022

2

Clínica Arvila Magna

Barcelona, Spain, 08037